Volume 18, Issue 4 (11-2026)                   Iran J Diabetes Obes. 2026, 18(4): 285-293 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shahriari G, Babaahmadi P, Arefzadeh A, Shiehmorteza M. Prevalence of Optimal HbA1c Levels in Type 2 Diabetes Mellitus Patients under Antidiabetic Treatment: A Cross-Sectional Study. , Iran J Diabetes Obes.. 2026; 18 (4) :285-293
URL: http://ijdo.ssu.ac.ir/article-1-1082-en.html
1- Student Research Committee, School of Medicine, Tehran Medical Sciences Islamic Azad University, Tehran, Iran.
2- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
3- Department of Endocrinology, Farhikhtegan Hospital, Faculty of Medicine, Tehran Medical Sciences Islamic Azad University, Tehran, Iran.
4- Department of Clinical Pharmacy, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran.
Abstract:   (29 Views)
Objective: Type 2 Diabetes Mellitus (T2DM) is a prevalent chronic disorder. Achieving stable, optimal HbA1C levels is crucial for managing T2DM. The objective of our current study is to determine the prevalence of controlled HbA1C levels among individuals who are diagnosed with T2DM and receiving antidiabetic medications.
Materials and Methods: Adult patients with T2DM and under antidiabetic medications enrolled in our study. From March 2023 to February 2024, 196 patients were recruited in this study. Data on demographic and clinical information extracted from the patient's records and HbA1C levels were measured. The association between different factors and the achievement of optimal HbA1C levels was evaluated among participants.
Results: Males achieved optimal HbA1c levels more frequently than females (80.2% vs 78.5). Regarding the type of medication, participants with oral medications represented glycemic control 55%, compared to 45% in those receiving injectable drugs. Moreover, we observed an inverse association between the duration of diabetes onset and glycemic control status. Our study showed no significant differences in the prevalence of controlled HbA1C levels based on age (P= 0.087), gender (P= 0.930), diabetes duration (P= 0.660), and medication type (P= 0.376).
Conclusion: Most of the patients with T2DM who were receiving antidiabetic medications achieved optimal HbA1C levels. It is recommended that additional education and support programs be provided to improve diabetes control and reduce its complications.
 
Full-Text [PDF 877 kb]   (8 Downloads)    
Type of Study: Original Article | Subject: Diabetes
Received: 2025/12/23 | Revised: 2026/03/13 | Accepted: 2026/05/18 | Published: 2026/11/18

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY 4.0 | Iranian Journal of Diabetes and Obesity

Designed & Developed by : Yektaweb